SCHEMBL13700243

SCHEMBL13700243

NC(=O)c1oc2c(F)cc(F)cc2c1NC(=O)c1ccc(CN(CCO)CCO)o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TSHR P16473 3/20 0.36
MAPK10 P53779 3/20 0.36
HSD17B10 Q99714 3/20 0.36
TP53 P04637 2/20 0.36
AHR P35869 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.34
GAA P10253 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
HDAC3 O15379 3/20 0.32
HDAC4 P56524 3/20 0.32
HDAC1 Q13547 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13700241 0.91 PTGDR2 (0.36) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL13700242 0.90 MAPT (0.40) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL13700233 0.90 MAPT (0.40) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL13700249 0.88 TSHR (0.38) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL13700228 0.87 SMYD3 (0.41) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL13700247 0.87 MAPT (0.39) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL13700250 0.85 KCNH2 (0.38) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL4255128 0.84 NPC1 (0.43) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL13700052 0.84 MAPT (0.39) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL13700239 0.84 GRM2 (0.40) MAPTSMN1; SMN2ALDH1A1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F MAPT 4025/4885SMN1; SMN2 2063/4885ALDH1A1 559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.